Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Thomas Claude Philippe Chantereau has worked on the following 1 EPO patent applications which have been published in the last five years:

EP14747592

USE OF ANTI-MUC1 MAYTANSINOID IMMUNOCONJUGATE ANTIBODY FOR THE TREATMENT OF SOLID TUMORS

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Sanofi, S.A.
Agent:
Thomas Claude Philippe Chantereau, Sanofi
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature